TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
SANA

Sana Biotechnology Inc

Healthcare · Biotechnology · —

3.10$ -7.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SANA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
94.9% 34.7% 52.6% 49.4% 54.0% 37.8% 32.1% 35.7%
89.2% 19.3% 17.1% 22.4% 21.5% 23.6% 25.5% 17.2%
89.2% 33.5% 51.8% 48.8% 51.5% 36.3% 30.4% 33.2%
1.7% 16.6% 15.1% 5.8% 8.1% – – –
0.0% 33.9% 19.3% 12.5% 17.1% 24.9% 28.1% 33.7%
– 14.3% 8.1% 5.2% 7.2% 10.5% 11.8% 14.2%
138.4% 134.3% 157.7% 35.5% 39.3% 49.1% 50.0% 61.4%
5.2% 4.7% 4.3% 8.8% 13.6% 11.4% 9.1% 18.9%
– 0.3% 0.5% 0.8% 1.5% 2.3% 2.5% 3.6%
0.8% 0.0% 0.3% 0.2% 0.3% 0.7% 1.0% 0.4%
-38.4% -34.3% -57.7% 64.5% 60.7% 50.9% 50.0% 38.6%
-38.6% -34.7% -58.8% -69.5% -128.2% -236.7% -320.3% -443.5%
545.7% 45.1% 25.7% 14.7% 22.9% 34.4% 46.1% 60.7%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?